Literature DB >> 29292265

[Risk factors for recurrence of large atherosclerotic cerebral infarction].

Ying-Yi Dai1, Zhi-Xin Huang, Xin-Tong Liu, Qi-Zhang Wang.   

Abstract

OBJECTIVE: To explore the risk factors for recurrence of large atherosclerotic cerebral infarction in first?episode patients.
METHODS: The consecutive patients with acute cerebral infarction diagnosed in the Department of Neurology were screened for large atherosclerotic cerebral infarction by CTA/MRA examination, and all the confirmed patients were followed up for 1 year. The patients were divided into recurrent ischemic stroke group and non?recurrent group according to occurrence of cerebrovascular events during the follow?up.
RESULTS: A total of 256 eligible patients were included in this study, and all of them completed the follow?up. During the 1?year follow?up, 30 (11.7%) patients had ischemic cerebrovascular stroke events. Univariate analysis showed significant differences in alcohol drinking (P=0.028), smoking (P=0.007), high?density lipoprotein cholesterol (HDL; P=0.045), ischemic heart disease (P=0.002), antihypertensive agents (P=0.036) and statin use (P=0.016) between the recurrent group and non?recurrent group. Cox regression analysis showed that irregular use of statins (RR=0.410, P=0.043), smoking (RR=2.253, P=0.043), HDL (RR=0.327, P=0.029), and ischemic heart disease (RR=8.566, P<0.001) were correlated with recurrent ischemic stroke.
CONCLUSION: The first?episode patients with irregular use of statins, low HDL levels, smoking and ischemic heart disease are at higher risks for having ischemic stroke recurrence.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29292265      PMCID: PMC6744025     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  28 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East.

Authors:  Hamidreza Saber; Amanda G Thrift; Moira K Kapral; Ashkan Shoamanesh; Amin Amiri; Mohammad T Farzadfard; Réza Behrouz; Mahmoud Reza Azarpazhooh
Journal:  Int J Stroke       Date:  2017-01-03       Impact factor: 5.266

Review 3.  Lifestyle Interventions to Prevent Cardiovascular Events After Stroke and Transient Ischemic Attack: Systematic Review and Meta-Analysis.

Authors:  Inger A Deijle; Sander M Van Schaik; Erwin E H Van Wegen; Henry C Weinstein; Gert Kwakkel; Renske M Van den Berg-Vos
Journal:  Stroke       Date:  2016-12-06       Impact factor: 7.914

4.  Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis Patients.

Authors:  I-Kuan Wang; Chung-Hsiang Liu; Tzung-Hai Yen; Jiann-Shing Jeng; Shih-Pin Hsu; Chih-Hung Chen; Li-Ming Lien; Ruey-Tay Lin; An-Chih Chen; Huey-Juan Lin; Hsin-Yi Chi; Ta-Chang Lai; Yu Sun; Siu-Pak Lee; Sheng-Feng Sung; Po-Lin Chen; Jiunn-Tay Lee; Tsuey-Ru Chiang; Shinn-Kuang Lin; Chih-Hsin Muo; Henry Ma; Chi-Pang Wen; Fung-Chang Sung; Chung Y Hsu
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-03-21       Impact factor: 2.136

5.  Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Authors:  Sammy Elmariah; Anthony J Furlan; Mark Reisman; David Burke; Moshe Vardi; Neil J Wimmer; Shuqiong Ling; Xiaohua Chen; David M Kent; Joseph Massaro; Laura Mauri
Journal:  JACC Cardiovasc Interv       Date:  2014-08       Impact factor: 11.195

Review 6.  High-risk carotid plaque: lessons learned from histopathology.

Authors:  Frank D Kolodgie; Kazuyuki Yahagi; Hiroyoshi Mori; Maria E Romero; Hugh H Trout; Aloke V Finn; Renu Virmani
Journal:  Semin Vasc Surg       Date:  2017-04-27       Impact factor: 1.000

Review 7.  Environmental Tobacco Smoke Exposure and Risk of Stroke in Never Smokers: An Updated Review with Meta-Analysis.

Authors:  Peter N Lee; Alison J Thornton; Barbara A Forey; Jan S Hamling
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-10-17       Impact factor: 2.136

Review 8.  Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

Authors:  Daniel Walcher; Nikolaus Marx
Journal:  Semin Immunopathol       Date:  2009-04-05       Impact factor: 9.623

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 10.  Secondary stroke prevention: challenges and solutions.

Authors:  Charles Esenwa; Jose Gutierrez
Journal:  Vasc Health Risk Manag       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.